drugset
drugset / Trial / NCT01415466

Pharmacokinetics and Drug Interaction Study Between Rosuvastatin and CS-866 in Healthy Male Volunteers

NCT01415466 ↗

Phase 1 Completed 36 enrolled Daewoong Pharmaceutical Co. LTD. Yonsei University · collab
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to evaluate the pharmacokinetics profile and drug-drug interaction between rosuvastatin and CS-866 in healthy male volunteers.

Timeline

Start
2011-08
Primary completion
2011-09
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Olmesartan medoxomil Unknown 40 mg —
Subject Rosuvastatin Small molecule 20 mg —

Indications

No indication recorded.